Jump to navigation
By Peter Hotez
This post is part of the #ProtectingKids blog series. Read the whole series here.
This blog was originally published by the Dengue Vaccine Initiative.
In its efforts to share first-hand testimonials from dengue-endemic countries, the Dengue Vaccine Initiative (DVI) asked Dr.
Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.